BioSpace News Archive

Pasithea Therapeutics Corp. announced the invention of a crystalline form of PAS-004 which is captured in polymorph and stereoisomer patent filings that when issued we believe will extend patent protection to at least 2045.

Affimed N.V. announced that Dr. Adi Hoess, Chief Executive Officer and member of the Management Board, will step down effective January 15, 2024.

Stoke Therapeutics, Inc. announced strategic priorities and anticipated milestones for 2024.

Charles River Laboratories International, Inc. announced that it will present at the 42nd Annual J.P. Morgan Healthcare Conference on Tuesday, January 9th, at 10:30 a.m. PST.

Leixir Dental Laboratory Group today announced the appointment of John Krier as Chief Executive Officer, effective January 2nd, 2024.

Scale Biosciences today announced the availability of three new datasets showcasing the performance of its newly released products, including the ScaleBio Single Cell Methylation Kit, ScaleBio Single Cell RNA Kit v1.1 with extended throughput, and ScaleBio CRISPR Guide Enrichment Kit, all of which are now shipping.

Butterfly Network, Inc. today announced the FDA clearance of its next-generation handheld point-of-care ultrasound (POCUS) system, Butterfly iQ3.

Neuronetics, Inc. today announced certain preliminary unaudited fourth quarter and full year 2023 results.

CorMedix Inc. announced several commercial and operational updates related to its business and anticipated launch of DefenCath®.

SI-BONE, Inc. announced its preliminary and unaudited revenue for fourth quarter and full year 2023.